Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Xingbin Hu
Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
67
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Clinical Significance of
PIK3CA
Mutation in Primary HER2-Positive Breast Cancer Treated with Anti-HER2 Therapy: A Systematic Review and Meta-Analysis
Number of pages: 31
Posted: 09 Dec 2022
Haizhu Chen
, Xingbin Hu,
Daquan Wang
,
Ying Wang
,
Yunfang Yu
and
Herui Yao
Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation and Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation
Downloads
67
(733,140)
View PDF
Download
Abstract:
Breast cancer, HER2-positive, anti-HER2 therapy, PIK3CA mutation, Predictive, Prognostic
Feedback
